Evidence map›Paper›PMID 33729443›Full record

ReviewBiochemical Society transactions2021

Recent developments in sustainably sourced protein-based biomaterials.

H Agnieray, J L Glasson, Q Chen, M Kaur, L J Domigan

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Natural Regenerative Hydrogels for Wound Healing.Gels (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Review
  9. Peptidomics.Nature reviews. Methods primers · 2023
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

H AgnieraySchool of Chemical Sciences, University of Auckland, Auckland, New Zealand.
J L GlassonDepartment of Chemical and Material Engineering, University of Auckland, Auckland, New Zealand.
Q ChenDepartment of Chemical and Material Engineering, University of Auckland, Auckland, New Zealand.
M KaurSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
L J DomiganDepartment of Chemical and Material Engineering, University of Auckland, Auckland, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research into the development of sustainable biomaterials is increasing in both interest and global importance due to the increasing demand for materials with decreased environmental impact. This research field utilises natural, renewable resources to develop innovative biomaterials. The development of sustainable biomaterials encompasses the entire material life cycle, from desirable traits, and environmental impact from production through to recycling or disposal. The main objective of this review is to provide a comprehensive definition of sustainable biomaterials and to give an overview of the use of natural proteins in biomaterial development. Proteins such as collagen, gelatin, keratin, and silk, are biocompatible, biodegradable, and may form materials with varying properties. Proteins, therefore, provide an intriguing source of biomaterials for numerous applications, including additive manufacturing, nanotechnology, and tissue engineering. We give an insight into current research and future directions in each of these areas, to expand knowledge on the capabilities of sustainably sourced proteins as advanced biomaterials.

Indexed as

Biocompatible MaterialsCollagenEukaryotic CellsGelatinKeratinsNanotechnologyProkaryotic CellsRecombinant ProteinsSilkTissue EngineeringBiocompatible MaterialsCollagenGelatinKeratinsRecombinant ProteinsSilkadditive manufacturingbiomaterial inksprotein biomaterialsprotein nanotechnologytissue engineering

Identifiers

PMID33729443
PMCPMC8106505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.